Ming-yan, H.E.; Zhu, B-Q.; Zhong, Y. Analysis of the incidence and mortality trend of breast cancer in Chinese women from 2005 to 2013. Ch. J. Dis. Control Prev., 2019, 23, 10-14.
Jun, W. Value of combined detection of tumor markers CA15-3, CA125, CEA and HER-2 in the diagnosis of breast. Xiandai Jianyan Yixue Zazhi, 2018, 33, 119-121.
Ling, X.U.; Yinhua, L.I.U. International guidelines on breast cancer and Chinese clinical practice. J. of Clin. Surgery, 2019, 27, 181-183.
Yao, X.; Song, H.; Yan, J. Progress in screening of breast cancer by mammography combined with altrasonography. J. Ch. Pract. Diagn. Ther., 2019, 33, 400-402.
Chen, Z.; Le, W.; Lingbin, D. The accuracy of mammography screening for breast cancer: A meta-analysis. Chin. J. Epidemiol., 2016, 37, 1269-1305.
Tang, S.; Wei, L.; Sun, Y. CA15-3 in breast secretions as a potential molecular marker for diagnosing breast cancer: A meta analysis.PLoS One, 2016, 11, 0-12.
Braden, A.M.; Stankowski, R.V.; Engel, J.M.; Onitilo, A.A. breast cancer biomarkers: Risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence. Curr. Pharm. Des., 2014, 20, 4879-4898.
Cai, W.; Cai, Z. The value of common tumor markers detection in clinical application. Ch. Contin. Med. Educat., 2019, 11, 64-66.
Wen, S.; Feng, Q.; Li, L. Value of three tumor markers detection in the follow-up of breast cancer., 2015, 12, 1356-1357+1360.
Qing, Z.; Lin, G. Recent advances in biomarkers of breast cancer. Chem. Life, 2018, 40, 85-90.
Chen, W.; Zheng, R.; Baade, P.D. Cancer statistics in China 2015. CA Cancer Clin., 2016, 66(2), 115-132.
Jia-Cun, L.I.; Luo, Z.; Hao, Q.L.J.C.T.M. Diagnostic significance of detection of plasma D-dimer and PAI-1 in COPD patients complicated with PTE by ROC curve. China Trop. Med., 2009, 5, 875-950.